HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kratom Experts Seek NIDA As Ally To Show Herb's Safety And Benefits

This article was originally published in The Rose Sheet

Executive Summary

American Kratom Association representatives also this week are lobbying state and local officials in Georgia to withdraw their findings linking 17 deaths directly to the use of kratom, and testifying at a Utah state legislative panel hearing on alternative pain remedies.

Advertisement

Related Content

Kratom Industry GMPs Target Swaying FDA By Exceeding Agency Standards
Kratom Group Sharpens Criticism Of 'Opioid' Finding In FDA's Report To DEA
FDA's Opioid Label For Kratom Called Misbranding By Marketers
FTC Curbs Another 'Free' Ride: Health And Wellness Industry News
Kratom Supplement Marketers Dispute FDA Warning, Ask For Review
FDA Turns Kratom's Future In US Dietary Supplement Market Into History
Kratom: All Questions On Pre-DSHEA Ingredient Evidence In One Package
Controversy Brews With 'Inaccurate' Reports Linking Kratom To Deaths
DEA Takes Comments On Kratom, But Keeps Eye On Scheduling

Topics

Advertisement
UsernamePublicRestriction

Register

RS121343

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel